Mesoblast Ltd Files 6-K with SEC

Ticker: MEOBF · Form: 6-K · Filed: Mar 1, 2024 · CIK: 1345099

Mesoblast LTD 6-K Filing Summary
FieldDetail
CompanyMesoblast LTD (MEOBF)
Form Type6-K
Filed DateMar 1, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, investor-relations

TL;DR

MESO filed a 6-K on Feb 29th with new announcements and investor decks.

AI Summary

On February 29, 2024, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement and investor presentation. The filing includes information for the month of March 2024 and pertains to their fiscal year ending June 30. The company is incorporated in Australia and its CEO is Silviu Itescu.

Why It Matters

This filing provides investors with updated information and presentations from Mesoblast Limited, offering insights into the company's recent activities and financial reporting.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer information and does not contain significant new financial or operational disclosures that would immediately impact risk.

Key Players & Entities

FAQ

What type of report is Mesoblast Limited filing?

Mesoblast Limited is filing a Form 6-K, which is a Report of Foreign Private Issuer.

When was the information in the Form 6-K filed?

The Form 6-K was filed as of February 29, 2024, and pertains to the month of March 2024.

Who is the Chief Executive Officer of Mesoblast Limited?

Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.

What exhibits are attached to this Form 6-K filing?

This Form 6-K filing includes Exhibit 99.1, which is a new release announcement, and an investor presentation.

Under which SEC Act is this report filed?

This report is filed under the Securities Exchange Act of 1934.

Filing Stats: 229 words · 1 min read · ~1 pages · Grade level 14.4 · Accepted 2024-02-29 18:15:50

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated March 1, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated February 29, 2024 . 99.2 Investor presentation of Mesoblast Ltd, dated February 29, 2024 .

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing